Medtronic (MDT -0.2%) says its received FDA clearance for its AIRvance Bone Screw System, allowing surgeons to perform a hyoid suspension procedure independently or in combination with other procedures for the treatment of obstructive sleep apnea. Under its previous FDA clearance, the hyoid suspension procedure was indicated as an adjunct to the tongue suspension procedure. With this clearance, the AIRvance System becomes the only approved stand-alone system available.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Thu, 5:10PM)
at Zacks.com (Tue, 4:53PM)
UPDATE: Medtronic plc: FDA Approves the VenaSeal Closure System for Treatment of Clinically Symptomatic Venous Refluxat Benzinga.com (Feb 24, 2015)
at Zacks.com (Feb 23, 2015)
at Investor's Business Daily (Feb 19, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs